Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy
© 2023. The Author(s)..
OBJECTIVES: The accurate prediction of post-hepatectomy early recurrence in patients with hepatocellular carcinoma (HCC) is crucial for decision-making regarding postoperative adjuvant treatment and monitoring. We aimed to explore the feasibility of deep learning (DL) features derived from gadoxetate disodium (Gd-EOB-DTPA) MRI, qualitative features, and clinical variables for predicting early recurrence.
METHODS: In this bicentric study, 285 patients with HCC who underwent Gd-EOB-DTPA MRI before resection were divided into training (n = 195) and validation (n = 90) sets. DL features were extracted from contrast-enhanced MRI images using VGGNet-19. Three feature selection methods and five classification methods were combined for DL signature construction. Subsequently, an mp-MR DL signature fused with multiphase DL signatures of contrast-enhanced images was constructed. Univariate and multivariate logistic regression analyses were used to identify early recurrence risk factors including mp-MR DL signature, microvascular invasion (MVI), and tumor number. A DL nomogram was built by incorporating deep features and significant clinical variables to achieve early recurrence prediction.
RESULTS: MVI (p = 0.039), tumor number (p = 0.001), and mp-MR DL signature (p < 0.001) were independent risk factors for early recurrence. The DL nomogram outperformed the clinical nomogram in the training set (AUC: 0.949 vs. 0.751; p < 0.001) and validation set (AUC: 0.909 vs. 0.715; p = 0.002). Excellent DL nomogram calibration was achieved in both training and validation sets. Decision curve analysis confirmed the clinical usefulness of DL nomogram.
CONCLUSION: The proposed DL nomogram was superior to the clinical nomogram in predicting early recurrence for HCC patients after hepatectomy.
KEY POINTS: • Deep learning signature based on Gd-EOB-DTPA MRI was the predominant independent predictor of early recurrence for hepatocellular carcinoma (HCC) after hepatectomy. • Deep learning nomogram based on clinical factors and Gd-EOB-DTPA MRI features is promising for predicting early recurrence of HCC. • Deep learning nomogram outperformed the conventional clinical nomogram in predicting early recurrence.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
---|---|
Enthalten in: |
European radiology - 33(2023), 7 vom: 14. Juli, Seite 4949-4961 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yan, Meng [VerfasserIn] |
---|
Links: |
---|
Themen: |
Contrast Media |
---|
Anmerkungen: |
Date Completed 26.06.2023 Date Revised 10.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00330-023-09419-0 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352935375 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352935375 | ||
003 | DE-627 | ||
005 | 20231226054843.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00330-023-09419-0 |2 doi | |
028 | 5 | 2 | |a pubmed24n1176.xml |
035 | |a (DE-627)NLM352935375 | ||
035 | |a (NLM)36786905 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yan, Meng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.06.2023 | ||
500 | |a Date Revised 10.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a OBJECTIVES: The accurate prediction of post-hepatectomy early recurrence in patients with hepatocellular carcinoma (HCC) is crucial for decision-making regarding postoperative adjuvant treatment and monitoring. We aimed to explore the feasibility of deep learning (DL) features derived from gadoxetate disodium (Gd-EOB-DTPA) MRI, qualitative features, and clinical variables for predicting early recurrence | ||
520 | |a METHODS: In this bicentric study, 285 patients with HCC who underwent Gd-EOB-DTPA MRI before resection were divided into training (n = 195) and validation (n = 90) sets. DL features were extracted from contrast-enhanced MRI images using VGGNet-19. Three feature selection methods and five classification methods were combined for DL signature construction. Subsequently, an mp-MR DL signature fused with multiphase DL signatures of contrast-enhanced images was constructed. Univariate and multivariate logistic regression analyses were used to identify early recurrence risk factors including mp-MR DL signature, microvascular invasion (MVI), and tumor number. A DL nomogram was built by incorporating deep features and significant clinical variables to achieve early recurrence prediction | ||
520 | |a RESULTS: MVI (p = 0.039), tumor number (p = 0.001), and mp-MR DL signature (p < 0.001) were independent risk factors for early recurrence. The DL nomogram outperformed the clinical nomogram in the training set (AUC: 0.949 vs. 0.751; p < 0.001) and validation set (AUC: 0.909 vs. 0.715; p = 0.002). Excellent DL nomogram calibration was achieved in both training and validation sets. Decision curve analysis confirmed the clinical usefulness of DL nomogram | ||
520 | |a CONCLUSION: The proposed DL nomogram was superior to the clinical nomogram in predicting early recurrence for HCC patients after hepatectomy | ||
520 | |a KEY POINTS: • Deep learning signature based on Gd-EOB-DTPA MRI was the predominant independent predictor of early recurrence for hepatocellular carcinoma (HCC) after hepatectomy. • Deep learning nomogram based on clinical factors and Gd-EOB-DTPA MRI features is promising for predicting early recurrence of HCC. • Deep learning nomogram outperformed the conventional clinical nomogram in predicting early recurrence | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Deep learning | |
650 | 4 | |a Hepatocellular carcinoma | |
650 | 4 | |a Magnetic resonance imaging | |
650 | 4 | |a Nomograms | |
650 | 4 | |a Recurrence | |
650 | 7 | |a gadolinium ethoxybenzyl DTPA |2 NLM | |
650 | 7 | |a Contrast Media |2 NLM | |
650 | 7 | |a Gadolinium DTPA |2 NLM | |
650 | 7 | |a K2I13DR72L |2 NLM | |
700 | 1 | |a Zhang, Xiao |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Bin |e verfasserin |4 aut | |
700 | 1 | |a Geng, Zhijun |e verfasserin |4 aut | |
700 | 1 | |a Xie, Chuanmiao |e verfasserin |4 aut | |
700 | 1 | |a Yang, Wei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Shuixing |e verfasserin |4 aut | |
700 | 1 | |a Qi, Zhendong |e verfasserin |4 aut | |
700 | 1 | |a Lin, Ting |e verfasserin |4 aut | |
700 | 1 | |a Ke, Qiying |e verfasserin |4 aut | |
700 | 1 | |a Li, Xinming |e verfasserin |4 aut | |
700 | 1 | |a Wang, Shutong |e verfasserin |4 aut | |
700 | 1 | |a Quan, Xianyue |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European radiology |d 1991 |g 33(2023), 7 vom: 14. Juli, Seite 4949-4961 |w (DE-627)NLM087691310 |x 1432-1084 |7 nnns |
773 | 1 | 8 | |g volume:33 |g year:2023 |g number:7 |g day:14 |g month:07 |g pages:4949-4961 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00330-023-09419-0 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 33 |j 2023 |e 7 |b 14 |c 07 |h 4949-4961 |